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Many signaling circuits face a fundamental tradeoff
between accelerating their response speed while
maintaining final levels below a cytotoxic threshold.
Here, we describe a transcriptional circuitry that
dynamically converts signaling inputs into faster
rates without amplifying final equilibrium levels.
Using time-lapse microscopy, we find that transcrip-
tional activators accelerate human cytomegalovirus
(CMV) gene expression in single cells without ampli-
fying steady-state expression levels, and this accel-
eration generates a significant replication advantage.
We map the accelerator to a highly self-cooperative
transcriptional negative-feedback loop (Hill coeffi-
cient 7) generated by homomultimerization of the
virus’s essential transactivator protein IE2 at nuclear
PML bodies. Eliminating the IE2-accelerator circuit
reduces transcriptional strength through mislocali-
zation of incoming viral genomes away from PML
bodies and carries a heavy fitness cost. In general,
accelerators may provide a mechanism for signal-
transduction circuits to respond quickly to external
signals without increasing steady-state levels of
potentially cytotoxic molecules.
INTRODUCTION
Biological signaling circuits, like electrical circuits, face a funda-
mental tradeoff between speed and amplitude (Alon, 2007;
Savageau, 1976). That is, a faster rate of initial increase is typi-
cally obtained at the cost of a higher steady-state level. This
tradeoff creates an evolutionary pressure when quick turn-on
of a signaling molecule is essential, but the signaling moleculeCis cytotoxic at high levels, as with inflammatory cytokines (Cau-
wels and Brouckaert, 2007), many viral systems (Dwarakanath
et al., 2001), and even the fever response (Roth et al., 2006).
For example, herpes viruses must quickly express viral genes
that modulate the host-cell environment into a replication-favor-
able state, but these genes often yield cytotoxic products when
expressed at high levels and can prematurely damage the cell
before an optimal number of viral progeny are produced. Here,
we investigate mechanisms that may optimize this ‘‘rate-
versus-level’’ tradeoff to generate a functional advantage.
We utilize the human herpes virus cytomegalovirus (CMV)
because many of the viral processes that alter the host-cell envi-
ronment have been well characterized (Mocarski et al., 2006).
CMV infects a majority of the world’s population and is a leading
cause of birth defects and a leading cause of morbidity and
mortality in the immunocompromised population. The virus initi-
ates an infectious program within the cell by expressing its
86 kDa viral transactivator protein Immediate-Early 2 (IE2), which
is a promiscuous transactivator of viral promoters and is essen-
tial for viral replication (Stinski and Petrik, 2008) but is also highly
cytotoxic (Dwarakanath et al., 2001; Sanders et al., 2008). CMV
must quickly express IE2 to establish a replication-favorable
environment but also limit IE2 levels to avoid prematurely
compromising the cell’s ability to produce viral progeny. IE2,
along with IE1, is encoded by a precursor mRNA expressed
from the CMV Major Immediate-Early (MIE) promoter, which
directs all subsequent viral gene expression and is considered
to be the chief regulator of the lytic cycle (Stinski and Petrik,
2008). The MIE promoter (MIEP) is exceptionally strong and
encodes multiple transcription factor-binding sites within its
500 nucleotide enhancer (Stinski and Isomura, 2008). The
MIEP is also autorepressed by IE2 via direct DNA binding to
a 12-nucleotide cis repression sequence (crs) located between
positions 13 and +1 relative to the transcriptional start site
(Macias and Stinski, 1993). The impact of IE2 autoregulation
upon the virus life cycle is largely unknown.ell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc. 1569
Figure 1. CMV Encodes an Endogenous
AcceleratorofGeneExpressionandAcceler-
ation Provides a Viral Replication Advantage
(A) Schematic of the CMV genome (230 kb) with
the MIE regulatory circuit (5 kb) expanded.
Increased inputs (transcriptional activation) to the
MIE promoter could result in either increased
output of protein levels (amplifier) or acceleration
of gene expression without amplification of level
(accelerator).
(B) The ‘‘response-vector’’ allows convenient
comparison between output time-lapse trajecto-
ries (i.e., white versus red points) in terms of
steady-state level versus the time to steady state.
Circuits that act as amplifiers respond to increased
input by shifting vertically or diagonally to the
upper right, whereas circuits that act as ‘‘acceler-
ators’’ respond by shifting horizontally left.
(C) Quantitative western blot analysis of IE2-
expression levels during CMV infection from 3
h.p.i., showing acceleration in presence of VPA
(pink) but no amplification in IE2 levels compared
to the untreated control (white).
(D) Response-vector map of western blot data.
VPA pretreatment (pink) decreases time to steady-
state without increasing steady-state IE2-YFP
levels when compared to the untreated control
(open circles).
(E) Single-cell time-lapse microscopy of IE2-YFP
levels for an untreated infection (open circles) and
infection in the presence of increasing exposure to
the histone-deacetylase inhibitor VPA (72 hr VPA
pretreatment in red, 24 hr VPA pretreatment in
pink). Each trajectory is an average of 20 cells with
± 1 SE in lighter background color.
(F) Response-vector map of single-cell micros-
copy data, showing that increasing VPA pretreat-
ment (pink, red) decreases time to steady-state
without increasing steady-state IE2-YFP levels
when compared to the untreated control (open
circles). Error bars (gray) = ±1 SE.
(G) Acceleration produces a significant fitness
advantage for the virus as measured by CMV wild-
type viral titers after a single round of infection
(measured by plaque forming units, PFU/ml) on the
peak day of viral production (day 4) after infection
at MOI = 1. Average viral titers are shown in the
absence of VPA (white) and for increasing VPA
exposure (red, pink); Error bars = ±1 SD. See also
Figure S1 and Movies S1, S2, S3.Using an integrated approach that couples mathematical
modeling with quantitative time-lapse microscopy, we show
that IE2 negative feedback is highly cooperative, which allows
the virus to overcome the rate-versus-level tradeoff (Figure 1A)
by accelerating IE2 gene expression without any measureable
increase in the steady-state expression level. To simplify
comparison of level and rate, we introduce the ‘‘response
vector,’’ which maps time-lapse trajectories into points on
a two-dimensional plane in terms of time to reach steady state
and level of expression. Circuits that respond upward (or upward
and to the right) in response-vector space are amplifiers,
whereas circuits that respond in a horizontal leftward direction,
like the IE2 circuit, are accelerators (Figure 1B). Strikingly, the1570 Cell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc.IE2 circuit appears to be a ‘‘pure’’ accelerator circuit that exhibits
an almost perfectly horizontal response vector. This finding may
lead to other examples where tuning the expression rate, rather
than the expression level, enhances fitness.
RESULTS
Transcriptional Acceleration Without Amplification
in CMV
We examined MIE gene-expression levels after increasing MIEP
activity by using transcriptional activators known to upregulate
MIEP activity (Choi et al., 2005; Fan et al., 2005; Hummel and
Abecassis, 2002). These transcriptional activators, Valproic
Acid (VPA), Trichostatin A (TSA), or Tumor Necrosis Factor Alpha
(TNF-a), appear to accelerate IE2 expression but do not amplify
IE2 protein levels, as measured by quantitative western blot
(Figures 1C and 1D, see also Figure S1 available online). To
test whether IE2 was being accelerated (but not amplified) within
single cells, quantitative live time-lapse microscopy was used to
track single cells undergoing infection by a recombinant CMV
encoding yellow fluorescent protein (YFP) fused to the IE2
open reading frame (Movie S1). This recombinant CMV IE2-
YFP virus replicates with wild-type kinetics and IE2-YFP levels
are equivalent to wild-type IE2 levels (Figure S1). In agreement
with previously reported IE2 fusion viruses, the IE2-YFP fusion
protein correctly localizes to ND10 domains during infection
(Sourvinos et al., 2007). Strikingly, increasing the activity of the
MIEP by VPA pretreatment significantly accelerates IE2 expres-
sion in single cells but does not amplify steady-state IE2 levels in
these single cells (Figures 1E and 1F)—a result also observed
under TSA or TNF-a treatment (Figure S1). Flow cytometry anal-
ysis (Figure S1), confirms that acceleration without amplification
is not an artifact of image processing.
To rule out the possibility that these results were caused by
changes in cell physiology induced by pretreatment with VPA
(or TSA or TNF-a), we also generated an IE2-YFP virus that
carried increased levels of the viral transactivator pp71 (Bresna-
han and Shenk, 2000) and confirmed that this pp71+ virus, with
high levels of packaged pp71 tegument factor, accelerates IE2
expression in the absence of pretreatment (Figure S1). As an
additional control, a generalized transcriptional activator that
does not specifically activate the MIE promoter during active
infection was used, and it fails to accelerate IE2 expression in
single cells (Figure S1). These controls argue that accelerated
rates of MIE expression result specifically from increased activa-
tionof theMIEpromoterandnot fromgeneralizedactivationof the
target cell. Thus, the MIE circuit appears to act as an ‘‘acceler-
ator’’ that allows only the rate of IE2 expression to changewithout
allowing significant change in the steady-state levels of IE2.
Acceleration Provides a Fitness Advantage for the Virus
Previous studies in RNA viruses have noted that small increases
in a single round of replication are sufficient to allow a viral strain
to competitively exclude other ‘‘less fit’’ strains in resource-
limited environments; in other words, the strain with the highest
basic reproductive number (R0), which is measured during a
single round of infection, wins and excludes all other competing
strains, even if that strain’s R0 is only marginally greater than the
closest competitor (Nowak and May, 2000).
To test whether acceleration of IE2 expression provides any
functional advantage for the virus, we analyzed viral replication
kinetics after the first round of viral maturation (96 hr) from cells
infected with CMV IE2-YFP virus (Figure 1G). The results show
that incremental increases in transcriptional activation, and the
resulting acceleration in MIE kinetics, generate correlated
increases in viral replication fitness with a 72 hr VPA pretreat-
ment, yielding an approximately 5-fold increase in viral replica-
tion compared to the untreated control. IE2 acceleration and
enhanced replication are also observed in the low-passage
clinical CMV isolate TB40-E, which exhibits a 9-fold increase in
titer (Figure S1).CAcceleration Without Amplification Requires Highly
Self-Cooperative Negative Feedback, and IE2 Exhibits
a Hill Coefficient, H, of H7
Next, we set out to identify the mechanisms driving acceleration
in the CMV MIE circuit. Based on previous studies showing
that negative feedback speeds a circuit’s ‘‘response time,’’
(i.e., the time required for a circuit to approach to its respective
steady-state level) (Black, 1999; Gardner et al., 2000; Kobayashi
et al., 2004; Rosenfeld et al., 2002; Savageau, 1976), we
hypothesized that acceleration without amplification would
likely utilize negative feedback. By employing a rate-balance
analysis, we find that negative feedback encoding a high
‘‘Hill’’ coefficient (H) is theoretically sufficient to generate accel-
eration without amplification (Figure 2A), whereas alternate
simple models cannot generate acceleration without amplifica-
tion (Supplemental Information, Figure S2), in agreement with
previous studies (Black, 1999; Rosenfeld et al., 2002; Savageau,
1976). Based on this analysis, we constructed a nonlinear
ordinary differential equation (ODE) model of the CMV MIE
circuit (Supplemental Information, Figure S2, Table S1) and
performed nonlinear least-squares regression of the model by
using the single-cell microscopy data to estimate the H value
of the IE2 negative feedback. H7 generates the best fit to
the single-cell time-lapse microscopy data (Figure 2B), and
sensitivity analysis demonstrates that H < 6 and H > 8 cannot
generate good fits to the data even when all other parameters
are allowed to vary across all physiological parameter space
(Figure S2). These simulation results demonstrate that a nega-
tive-feedback model with a high H is sufficient to generate
acceleration without amplification and predict that the IE2
circuit requires negative feedback with H[ 1 to function as
an accelerator.
H is traditionally measured by dose-response approaches,
which are ‘‘open loop’’ (i.e., feedback is removed from the
system). However, for transactivators that are cytotoxic at
high doses, such as IE2, the dose-response method destroys
the cell before the response can be measured (data not
shown). To circumvent this cytotoxicity problem, we developed
a ‘‘closed loop’’ single-cell analysis method to analyze how a
circuit’s output (steady-state protein levels) saturates as a
function of increasing promoter activation and varying H
values (Figure 2C). This method essentially measures the
change in steady-state levels as a function of increasing
promoter strength.
To measure H via this closed-loop method, flow-cytometry
measurements of steady-state GFP levels were collected for
a minimal negative-feedback circuit encoding the full-length
MIEP driving IE2 and GFP (MIEP-IE2-IRES-GFP) and compared
to a minimal nonfeedback circuit encoding the full-length MIEP
driving GFP (MIEP-mCherry-IRES-GFP), which acts as the non-
feedback control circuit. By increasing the MIEP activity with
transcriptional activators (e.g., TSA or VPA) the response of
each circuit can be measured (Figure 2C), and these responses
can then be compared to theoretically predicted responses for
varying H levels (Figure 2C). As expected for the nonfeedback
circuit, a linear increase in activator results in a linear increase
in GFP steady-state levels (black). However, for the MIEP-IE2-
IRES-GFP negative-feedback circuit (red), the equivalent linearell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc. 1571
Figure 2. Highly Self-Cooperative Negative Feedback Is Needed to
Generate an Accelerator Circuit and IE2 Encodes Negative Feed-
back with a High Hill Coefficient, H7
(A) Schematic and rate-balance analysis of a simplified negative-feedback
model: dx=dt = ðb=ðkH + xHÞÞ  d,x for different values of the Hill coefficient (H).
The dashed gray line represents the decay rate, whereas solid lines (black and
pink) represent synthesis rates for increasing values of b (1.0 and 1.5,
respectively), which accounts for induction by a transcriptional activator that
increases basal promoter activity by 1.5-fold. The points at which solid and
dashed lines meet represent the steady states, and the distance separating
the solid and dashed lines represents the rates of expression. Rate-balance
analysis is shown for four values of H. High values of H allow the expression
rate to increase without amplification in the steady-state level. Insets:
response vectors showing the change in steady-state level and the change in
time to steady state for each H value.
1572 Cell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc.increase in activator input results in a significant saturation in
GFP steady state. This saturation in the GFP steady-state values
is consistent with the regression analysis, indicating H  7 for
IE2 negative feedback. These results indicate that IE2 negative
feedback acts early during CMV infection (i.e., during the first
12 hr), which has not been reported. Taken together, the results
demonstrate that the IE2 circuit encodes a highly self-coopera-
tive negative feedback with an H value sufficient to generate
an accelerator that effectively abolishes IE2 amplification under
different inputs.
Highly Self-Cooperative IE2 Feedback Results from IE2
Homo-Multimerization
We suspected that the high H value might be due to IE2 homo-
multimerization, based on (1) in vitro biochemical studies report-
ing that IE2 peptide fragments can homomultimerize when
binding to DNA (Chiou et al., 1993; Waheed et al., 1998), and
(2) well-characterized mechanisms in other negative-regulation
circuits encoding H > 1 (Chen et al., 1994; Hooshangi et al.,
2005). To assay for IE2 homomultimerization in real time during
CMV infection, we utilized polarization anisotropy Fo¨rster Reso-
nance Energy Transfer (FRET) imaging, which can differentiate
between monomers and higher-order homomultimers (Gautier
et al., 2001). During the first 16 hr of infection, IE2-YFP exhibits
a strong homo-FRET anisotropy (r) signal corresponding to
high-order IE2 homomultimerization (Figure 3A).
We next used an established theoretical model (Runnels and
Scarlata, 1995) to estimate the number of individual IE2 mono-
mers that might be interacting within an IE2 homomultimer to
generate the measured polarization anisotropy signal. Although
the model cannot precisely calculate the number of monomers
making up the homomultimer—because the distance between
individual IE2 monomers is not known—a lower limit on the
number of IE2 monomers within the homomultimer can be esti-
mated with confidence, under the most conservative assump-
tion that the distance between each IE2-YFP monomer is the
diameter of the YFP molecule (24 A˚). Under this maximally
conservative assumption, the measured anisotropy shift
ðrR0:5/rz0:1Þ is consistent with an IE2 homomultimer
composed of at least five to six IE2 monomers (Figure 3B).(B) Nonlinear least-squares regression of single-cell time-lapse microscopy
data from Figure 1E to a mathematical model of the CMV MIE circuit
(Supplemental Information) showing the best-fit curve of H = 7.3 (right). Gray
data points are untreated trajectories from Figure 1D, whereas pink data points
are VPA+ trajectories from Figure 1D. Poor data fits are generated when H is
fixed at H = 1 or H = 0 (no feedback) despite letting all other free parameters in
the model vary (middle and left, respectively); sensitivity analysis shows that
setting H < 6 or H > 8 generates poor fits to the data (Figure S2).
(C) Closed-loop dose-response analysis to measure H for the IE2 circuit.
Left: steady-state solutions for the minimal negative-feedback ODE
model (from A) as a function of increasing basal promoter strength b for
different H values. Right: live-cell flow cytometry measurements of a non-
feedback CMV MIEP-mCherry-IRES-GFP control circuit (black) and a minimal
negative-feedback CMV MIEP-IE2-IRES-GFP circuit (red) induced to different
levels of activation by TSA treatment. CMV MIEP-mCherry-IRES-GFP shows
a linear increase in final level, whereas CMV MIEP-IE2-IRES-GFP shows
saturation in steady-state level consistent withH7. See also Figure S2, Table
S1, and Movie S4.
Figure 3. IE2 Forms a High-Order Homo-Multimer that Can Account
for a High H Value
(A) Direct measurement of IE2 homomultimerization by two-photon steady-
state homo-FRET in live cells during CMV infection. CMV IE2-YFP-infected
cells were imaged to determine fluorescence polarization anisotropy (r) at 15 hr
postinfection and compared to cells infected with a control CMVGFP virus. An
r z 0.5 represents no FRET exchange and is the two-photon theoretical
maximum anisotropy for a GFP or YFP monomer. IE2-YFP exhibits significant
depolarization and homo-FRET exchange in the nucleus and especially at
subnuclear foci, indicating the presence of a high-order IE2 homomultimer.
(B) Calculation of a lower limit for the number of IE2 monomers present in the
IE2 multimer, based on measured anisotropy values. Plotted surface is the
solution to the theoretical formula that accounts for the number of IE2-YFP
monomers (N) in a complex participating in FRET exchange that could
account for a given value of r based on the distance between each monomer
(R). The formula estimates a lower limit for YFP monomers in a homomultimer
that could generate a given r. Under the maximally-conservative assumption
that all YFP monomers are as tightly packed as physically possible (R =
24 A˚), the minimum number of IE2-YFP monomers participating in homo-
FRET exchange that could generate an anisotropy value of r = 0.1 is
approximately 6. See also Figure S3.Importantly, the IE2-YFP monomers are likely separated by
>24 A˚, and the results of Figure 3B show that the measured
anisotropy shift is well within the theoretical range of IE2 forming
a homoheptamer or higher order homomultimer at the ND10 foci.
Measurements of IE2 diffusion kinetics from fluorescence
recovery after photobleaching (FRAP), support the assertion
that IE2 aggregates atND10domains in infected cells (FigureS3).
Despite these direct measurements of IE2 homomultimerization
in live cells during active infection, structural studies would defin-
itively establish the presence of a high-order IE2 homomultimer
bound to DNA.
In summary, results from three independent measurements,
namely (1) regression fitting of a minimal ODE model to single-Ccell CMV IE2-YFP trajectories, (2) the ‘‘closed-loop’’ analysis of
the isolated IE2 feedback circuit, and (3) homo-FRET imaging
of IE2-YFP, all point toward the IE2 negative-feedback circuit
as operating with a high Hill coefficient (H 7). These data argue
that IE2 homomultimerization is a core factor in establishing the
high Hill coefficient of this transcriptional negative-feedback
circuit, and that homomultimerization underlies the circuit’s
ability to act as an accelerator.
A Minimal-Accelerator Circuit Provides a Fitness
Advantage outside the Infection Setting
To verify that highly self-cooperative negative feedback is suffi-
cient to generate an accelerator, we reconstructed a minimal
IE2 feedback circuit lacking all other viral elements and analyzed
it completely outside the virus infection setting. The minimal IE2
feedback circuit was constructed using a lentiviral vector ex-
pressing only IE2 and GFP from either the full-length wild-type
MIEP or a mutant version of the MIEP in which three nucleotides
in the crs-binding site are mutated to eliminate IE2 binding
(Macias and Stinski, 1993) (Figure 4A). Both wild-type and
mutant Dcrs lentiviral circuits were stably integrated into the
cellular genome. The minimal wild-type circuit stably expresses
IE2 (Figure S4), and two-color imaging confirms that the MIEP
exhibits comparable kinetics both within the context of the virus
and stably integrated in host-genome DNA (Figure S4). As
predicted from the model, the minimal mutant circuit exhibits
substantially increased mean GFP fluorescence intensity (Fig-
ures 4B and S4). The minimal mutant circuit fails to generate
acceleration, instead acting as an amplifier (Figure 4C), whereas
the wild-type feedback circuit generates acceleration (Fig-
ure S4), even in the absence of all other viral elements. Cells
carrying the wild-type accelerator circuit also exhibit a profound
viability advantage over cells carrying mutant amplifier circuit
(Figure 4D). Dramatically, cell populations carrying the minimal
wild-type accelerator circuit maintain IE2 and GFP expression,
whereas cell populations carrying the minimal mutant circuit
exhibit a rapid loss of IE2 and GFP expression that increases
over time (Figures 4E and S4). Genomic PCR (Figure 4F)
confirms that loss of IE2 and GFP expression is due to a loss
of cells carrying the stably integrated mutant circuit, not from
silencing of the integrated MIEP. These data argue that cells
carrying the mutant circuit express higher IE2 levels and
undergo increased cell death, leading to these cells being out-
competed from the population. Thus, a minimal IE2 accelerator
circuit provides cells with a dramatic fitness advantage over a
comparable IE2 amplifier circuit, even in the absence of all other
viral factors.
Converting the Accelerator to an Amplifier Generates
a Severe Fitness Cost for the Virus
To determine whether negative feedback is necessary for the
MIE circuit to act as an accelerator in the context of the virus,
we constructed a Dcrs virus by bacterial artificial chromosome
(BAC) mutagenesis of the three nucleotides in the crs-binding
site (Figure 5A). In agreement with modeling predictions and
the minimal circuit observations (Figure 4), thisDcrsmutant virus
acts as an amplifier generating a 1.5-fold amplification in
single-cell expression levels in the presence of MIEP activatorsell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc. 1573
Figure 4. A Minimal IE2 Accelerator Circuit
Provides a Fitness Advantage Outside the
Context of Viral Infection
(A) Schematics of the minimal wild-type acceler-
ator circuit MIEP-IE2-IRES-GFP (left) and minimal
mutant amplifier circuit MIEPDcrs-IE2-IRES-GFP
(right). Both circuits are lentiviral vectors and
encode an IRES element between IE2 and GFP.
(B) Flow cytometry density plot of cells stably ex-
pressing the wild-type accelerator (left) or the
mutant amplifier (right) circuit that exhibits8-fold
higher mean GFP.
(C) Fold increase in GFP for the wild-type accel-
erator and mutant amplifier circuits in the absence
(white, black) or presence (red) of TSA.
(D) Percentage of live cells (by flow cytometry)
after 14 days of TSA treatment. TSA treatment has
little effect on viability of cells expressing the wild-
type accelerator circuit (white) but leads to signif-
icantly decreased viability in cells expressing the
mutant amplifier cells (black).
(E) Flow cytometry time-course of the % of GFP
expressing cells for the accelerator (white) and
amplifier (black) circuits. GFP expression is lost
from the cells transducedwith themutant amplifier
circuit but is maintained in cells transduced with
wild-type accelerator circuit (averages of three
replicates shown in bold with ±1 SD).
(F) PCR amplification of the MIEP locus from:
cellular genomic DNA of cells transduced with
either wild-type accelerator circuit or mutant
amplifier circuit on day 14 (lanes 1 and 2); plasmid
DNA of wild-type accelerator or mutant amplifier
lentiviral vector (lanes 3 and 4, positive PCR
controls); naive nontransduced cells, negative
control (lane 5). At day 14, the mutant amplifier
circuit has been lost from the genomic DNA of
the transduced population but the wild-type
accelerator circuit remains present in the genomic
DNA of the transduced population. See also
Figure S4.(Figures 5B and S5) and exhibits virtually no acceleration
(Figure 5C).
Strikingly, replication of this mutant amplifier virus is severely
compromised in the presence of activators (Figures 5D and
S5). These data agree with the minimal-circuit data that amplifi-
cation of IE2 levels is deleterious for the cell, leading to
decreased viral output. Potential toxicity of VPA or TSA exposure
alone cannot account for reduced viral replication because
neither activator reduces replication fitness of the parent virus
(Figure S5).
To rule out secondary mutations outside the crs region
that could be responsible for amplification, these results were
verified in two independently isolated BAC clones and
sequencing 1 kb upstream and downstream of the crs verified
the absence of secondary mutations (data not shown). The
generation of a ‘‘rescue’’ virus with wild-type IE2-expression1574 Cell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc.kinetics (described below and in Figure 7)
independently verifies that secondary
mutations do not account for the amplifierphenotype or reduced fitness. This absence of secondary
mutations is not unexpected given the reported stability and
specificity of BAC mutagenesis for CMV (Reddehase and Lem-
mermann, 2006).
The Loss of the Accelerator Circuit in the Dcrs Amplifier
Mutant Is Buffered by Reduced MIEP Activity through
Mislocalization of Incoming Viral Genomes
Although theory predicts that removal of negative feedback
should increase IE2 steady-state levels (as in theminimal circuit),
the biology of IE2 cytotoxicity and the presence of the acceler-
ator circuit in the wild-type virus suggest that over the course
of viral evolution, there is strong selection for mechanisms to
maintain low IE2 levels. Therefore, to determine how the Dcrs
amplifier mutant virus can maintain any viability even in the
absence of activators (Figure 5D), we tested whether IE2
Figure 5. Converting the IE2 Accelerator to an Amplifier—by
Eliminating Negative Feedback—Generates a Severe Fitness Cost
for the Virus
(A) Schematic of the mutant CMV Dcrs mutant virus.
(B) Single-cell time-lapse microscopy of cells undergoing infection with CMV
Dcrsmutant in presence of 24 hr pretreatment of VPA (pink) or absence of VPA
(black). Trajectories are averages of 20 cells (bold) together with ±1 SE (lighter
background). The CMV Dcrsmutant displays an 1.5-fold amplification in IE2
levels in single cells in response to VPA.
(C) Response-vectormap of single-cell microscopy data showing that theDcrs
mutant virus amplifies steady-state IE2-YFP levels compared to the untreated
control (black). Error bars (gray) = ±1 SE.
(D) Replicative fitness of the CMV Dcrs mutant in presence (red) and absence
(black) of a 72 hr VPA treatment as measured by PFU/ml on the peak day of
viral production (day 10) after infection at MOI = 1. Average values are shown
with ±1 SD. Decreased replication is not due to drug toxicity on the infected
cells (see Figure S5).
Cuntreated steady-state levels are increased, similar to the
minimal circuit setting, or whether the mutant virus employs
compensatory mechanisms to keep IE2 levels low. Single-cell
imaging and flow cytometry analysis reveal that IE2 steady-
state levels in the Dcrs mutant amplifier virus (in the absence
of activators) are essentially the same as IE2 levels in the
wild-type virus (Figures 6A and S6) but the rate of IE2 expres-
sion is significantly slower in the mutant (Figure 6B). Based on
literature indicating that subnuclear PML bodies facilitate tran-
scription from the MIEP (Sourvinos et al., 2007), we tested
whether reduced IE2 levels were the result of decreased
MIEP activity due to Dcrs mutation-induced mislocalization of
incoming viral genomes away from PML bodies. Although the
wild-type virus exhibits IE2 localization to PML bodies, the
Dcrs mutant virus displays virtually no IE2-positive foci during
early infection (Figure S3), and immunofluorescence analysis
shows that Dcrs mutant viral genomes do not colocalize with
PML bodies (Figure 6C). To confirm that PML-body mislocaliza-
tion reduces IE2 levels, we infected a cell line lacking PML
bodies (Everett and Chelbi-Alix, 2007) and observed signifi-
cantly reduced steady-state IE2 levels (Figure 6D). In summary,
the Dcrs mutant amplifier virus appears to compensate for the
lack of accelerator circuitry by reducing MIEP transcriptional
strength, through misdirecting incoming viral genomes away
from sub-nuclear PML bodies.
The minimal circuit is integrated into the genome as a single-
copy lentiviral provirus and MIEP does not appear to be influ-
enced by PML body localization in this context.
Reduced MIEP Activity Decelerates IE2 Expression
and Carries a Heavy Fitness Cost
Because the amplifier mutant and wild-type accelerator viruses
exhibit equivalent IE2 steady-state levels but different rates of
IE2 expression, we next tested whether the mutant’s reduced
fitness could be rescued by acceleration. To do this, we provided
the mutant virus with the opportunity to regain accelerator
circuitry through homologous recombination, by cotransfecting
cells with the fullDcrsmutant virus genome together with a short
1 kb DNA fragment of the MIEP encoding the wild-type crs
sequence. This approach to generate recombinant ‘‘rescue’’
virus (Figure 7A) creates a ‘‘fitness competition’’ because
the mutant must compete with any rescue that arises within
the culture. After culturing the cotransfected cells for 2 weeks
(the typical time for growth of CMV IE2-YFP in culture), all
observable CMV-positive plaques analyzed are rescue virus
that exhibit accelerated expression kinetics (Figure 7B), and
fitness comparable to that of wild-type virus (Figure 7C). The
fact that high-titer accelerator rescue virus can be isolated
from a background Dcrs infection while no detectable Dcrs virus
can be isolated from this background indicates that viruses
encoding the accelerator circuit directly outcompete viruses
encoding the mutant amplifier even in the absence of transcrip-
tional activator drugs. Sequencing results confirm that in the
rescue virus theDcrs locus is restored to the wild-type sequence
and that the rescue virus exhibits a complete recovery of the
accelerator phenotype (Figure S7). These results show that
a slower rate of IE2 expression is sufficient to generate a heavy
fitness cost even when IE2 levels are not elevated.ell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc. 1575
Figure 6. Mutation of the crs in the CMV
Genome Results in Inefficient Formation of
IE Transcriptional Centers and Lower IE2-
YFP Expression
(A) Single-cell time-lapse microscopy analysis
comparing CMV IE2-YFP virus, referred to as ‘‘wild
type’’ (white), to Dcrs amplifier mutant virus
(black); infections imaged in parallel on the
same day under the same conditions. Error bars
(gray) = ±1 SE.
(B) Response-vector map showing that the Dcrs
amplifier mutant virus (black) exhibits decelerated
IE2 kinetics but no change in IE2 steady-state level
compared to wild-type (white). Error bars = ± 1 SE
(C) Immunofluorescence micrographs of cells
infected with either wild-type CMV (top) or the
Dcrs mutant virus (bottom) and stained for CMV
genome (red), PML protein (green), and DNA
(blue). CMV genomes and PML bodies appear
to colocalize at a significantly higher frequency
(p < 0.01) in cells infected with wild-type CMV virus
compared to Dcrs amplifier mutant virus. Insets:
representative colocalization of CMV genomes
and PML bodies.
(D) Steady-state IE2-YFP levels from single-cell
microscopy in conventional PML+ cells (green)
cells or PML- knockdown cells (black). Both cell
types were infected with ‘‘wild-type’’ CMV IE2-
YFP virus. Bold black lines in the box plot are the
median IE2-YFP levels, boxes represent lower
and upper quartile, and whiskers represent 1.5
interquartile range (IQR) of the lower and upper
quartiles. PML knockdown significantly reduces
IE2-YFP levels (p < 0.001). See also Figure S6.DISCUSSION
This study characterizes an endogenous accelerator circuit, and
shows that acceleration of transcriptional response time, without
modulation of steady-state levels, can confer a fitness advan-
tage. The fitness advantage is unlikely to result solely from faster
IE2 expression but rather from IE2 driving acceleration of down-
stream viral expression, because viral cytopathic effect (CPE) is
observed earlier when IE2 kinetics are accelerated (Movies S2
and S3), and other key steps in the viral life cycle are decelerated
in Dcrs viruses (Isomura et al., 2008). Conversely, it is unlikely
that the fitness advantage results from non-IE2-driven alternate
pathways because the same transcriptional activators that
generate acceleration in the wild-type virus generate amplifica-
tion with severe fitness loss in the Dcrs mutant amplifier virus
and in minimal synthetic circuits where only the accelerator
has been removed. The alternate pathway hypothesis is also
difficult to reconcile with our finding that MIEP activators1576 Cell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc.(pp71, VPA, TSA, and TNF-a) generate
acceleration, whereas broad-spectrum
non-MIEP activators (5Aza-C) cannot
generate acceleration (Figure S1). The
finding that a rescue virus (which only
differs in rate of IE2 expression not level)
outcompetes the Dcrs amplifier mutant,further argues that the expression rate drives the fitness advan-
tage. These findings demonstrate a functional role for IE2 nega-
tive feedback in maintaining viral fitness.
The unique architecture of IE2 negative feedback and the
circuit’s ability to act as an accelerator lies in the high Hill coeffi-
cient, H  7, which to our knowledge is the highest value yet
recorded for a transcriptional autoregulatory circuit. Although
a number of mechanisms can generate high H values, including
multiple binding sites for an autoregulatory protein on the target
DNA (Ozbudak et al., 2004) or sequential covalent modifications
of an autoregulator (Deshaies and Ferrell, 2001), in the case of
IE2 the H value may be explained by formation of a homomul-
timer, consisting of six to eight IE2 protein monomers that form
at or around the 12 bp crs DNA-binding site for IE2. The forma-
tion of such a large homomultimer leads to the question of how
a 12 bp sequence of DNA (just over 40 A˚ in length) might have
the steric space requirements to support binding of this homo-
multimer complex, which is likely over half a megadalton with
Figure 7. Loss of IE2 Acceleration, Despite
Equivalent IE2 Levels, Carries a Heavy
Fitness Cost
(A) Schematic of ‘‘rescue’’ experiment that
represents a growth competition between the
Dcrs amplifier mutant virus and ‘‘wild-type’’ CMV
IE2-YFP.
(B) Response-vector map of single-cell micros-
copy showing that the rescue virus (green)
generated from the mutant amplifier virus (black),
has regained the accelerated expression kinetics
of the wild-type virus (white) and all viruses exhibit
equivalent IE2-YFP steady-state levels; all viruses
(wild-type, mutant, and rescue) were imaged in
parallel on the same day under the same condi-
tions. Error bars (gray) = ±1 SE.
(C) Viral replication titers for the rescue virus
(green) compared to Dcrs amplifier mutant
(black) and wild-type viruses (white) as measured
by PFU/ml on the peak day of viral production
in a multistep assay (MOI = 0.1). Despite all
viruses exhibiting equivalent IE2-YFP steady-state
levels, the rescue virus, which has reacquired the wild-type accelerator, replicates with the same high efficiency as wild-type virus, whereas the Dcrs amplifier
mutant virus exhibits a severe fitness disadvantage. Averages are shown in bold gray with ±1 SD. See also Figure S7.a diameter >120 A˚, approximately three times as large as the
DNA-binding site itself. Notably, the eukaryotic transcription
factor Sp1 binds a 10 bp DNA sequence as a homotetramer
(Haase, 2010), and many viral proteins cooperatively homomul-
timerize to bind short palindromic DNA sequences, including
the Rep 78/68 protein in adeno-associated virus, the SV40
large T antigen, and bovine papillomavirus type 1 E1 protein—
all of which form homohexamers on short palindromic DNA
sequences (Flint and American Society for Microbiology, 2009).
Thus, homomultimer formation appears to be a property shared
among diverse proteins involved in viral replication as a way to
bind short, palindromic DNA sequences. The high cooperativity
of IE2 regulation may also be influenced by ‘‘conditional cooper-
ativity’’ (Garcia-Pino et al., 2010) because other host and viral
factors, such as viral UL84, functionally interact with IE2 during
the viral lifecycle (Gebert et al., 1997) and numerous covalent
modifications of IE2 are reported to influence functionality (Bar-
rasa et al., 2005; Hofmann et al., 2000). In general, highly self-
cooperative negative feedback may provide a generic mecha-
nism to optimize the rate-versus-level tradeoff.
The Mechanics of the Accelerator Circuit in Relation
to Other Negative Autoregulatory Circuits
Negative feedback has long been known to speed a circuit’s
response time (Black, 1999; Rosenfeld et al., 2002; Savageau,
1976), which is the time required for a circuit to reach its
steady-state level or some fixed percentage of its steady-state
level (e.g., 50%). Compared to nonfeedback circuits, circuits
encoding negative feedback (i.e., autoregulation) approach
a lower steady-state level but attain this relative steady-state
level faster. However, a long-running biological counterargu-
ment has been that transcriptional circuits must cross an abso-
lute threshold (e.g., 10 molecules) and negative feedback
necessarily slows (not speeds) this crossing. This incongruity,
in which negative feedback speeds response time but slowsCthreshold crossing, has led to a controversy regarding the kinetic
role of negative feedback.
It has been argued that response time (i.e., 50% of some rela-
tive steady-state level) is amisleadingmeasure and that negative
feedback has no functional role in accelerating responses. The
accelerator circuitry characterized here addresses this contro-
versy because it acts as a hybrid between nonfeedback and
feedback circuits. Rate-balance analysis (Figure 2A and Movie
S4) shows that as the self-cooperativity is increased, the accel-
erator circuit behaves more and more like a nonfeedback circuit
at low IE2 concentrations, allowing for faster crossing of an
absolute molecular threshold. As IE2 levels approach the
concentration threshold where self-cooperative negative feed-
back becomes active, feedback turns on very quickly (and at
almost maximum strength) and sharply autorepresses the
MIEP to keep the steady-state level from changing under
different inputs. In the framework of electrical-circuit theory,
the accelerator inverts the typical input/output transfer function
and dynamically redistributes the ‘‘gain-bandwidth’ relationship
(see Supplemental Information). It is possible that diverse
signaling pathways that employ negative feedback utilize this
inversion of input/output as a means of signal discrimination
or as a mechanism to approximate ‘‘perfect adaptation’’ (Ma
et al., 2009; Muzzey et al., 2009) in steady-state levels. The
high cooperativity in negative feedback may also function to
suppress stochastic fluctuations (i.e., noise) that influence the
behavior of decision-making circuits (Cagatay et al., 2009).
Potential Roles for the Accelerator Circuit
in the Evolution of Virulence
Why might CMV have evolved the accelerator architecture over
other potential mechanisms to maintain low levels of IE2? CMV’s
lifecycle in vivo involves replication in diverse cell types and host
conditions, and the strong, easily activatedMIEP is well suited to
activate under these diverse conditions. The MIEP’s strength isell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc. 1577
due to numerous enhancer-binding sites that have the potential
to generate large amplifications of input signal through combina-
torial binding (Carey et al., 2009). Consequently, CMV’s acceler-
ator circuit may have evolved as a natural consequence of the
strong MIEP to counteract and limit the inevitable amplification
of signal from MIEP. An alternate mechanism would be to
enhance the basal-expression strength of the MIEP, while
simultaneously increasing the decay (i.e., turnover) rate of IE2.
This strategy would be difficult to achieve for CMV because
the MIEP is one of the strongest known promoters and the IE2
half-life is 2.5 hr (Figure S6). Given this short half-life of IE2,
coupled with the already exceptional strength of the MIEP, it
may not be possible to further reduce IE2 half-life (while main-
taining its essential functions) or increase the unstimulated
MIEP activity level. However, this strategy may have been an
evolutionary precursor to the accelerator circuit.
In settings where host responses lead to high viral loss, faster
expression, and increased viral output in response to inflamma-
tory or innate-defense factors may enable the virus to outpace
host defenses. Thus, tuning of the expression rate may have
evolved as a viral countermeasure to outpace the host cell’s
innate immune defenses. Because these considerations are
not unique to CMV infection, accelerator circuitry may be awide-
spread architecture among gene-regulatory circuits.
EXPERIMENTAL PROCEDURES
Cloning of Recombinant Viruses
The CMV IE2-YFP virus was constructed by inserting EYFP (Clontech) to the 30
end of IE2 exon 5 in the parent AD169 as described (Moorman et al., 2008; Yu
et al., 2002).
The CMV GFP control virus (Yu et al., 2003) encodes an SV40 promoter-
EGFP cassette. The CMV Dcrs IE2-YFP virus was constructed from the
CMV IE2-YFP background as described (Cuevas-Bennett and Shenk, 2008).
Viral stocks were titered by TCID50 (Nevels et al., 2004). To verify the integrity
of the CMV Dcrs IE2-YFP virus, a rescue virus, CMV DcrsREVERT IE2-YFP,
was constructed by homologous recombination, whereby CMV Dcrs IE2-
YFP BAC DNA (20 mg) and a 2.5 kb wild-type MIEP DNA fragment (2.5 mg)
were cotransfected by electroporation into 106 MRC5 cells and subjected to
two rounds of plaque purification.
Cell-Culture Conditions and Drug Perturbations
MRC5 fibroblasts and life-extended human foreskin fibroblasts (HFFs) (Bres-
nahan and Shenk, 2000) were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and
50 U/ml penicillin-streptomycin at 37C and 5%CO2 in a humidified incubator.
ARPE-19 cells were maintained in a 1:1 mixture of DMEM/F-12 (Mediatech)
with 10% FBS (HyClone) and 50 U/ml Penicillin-Streptomycin (Mediatech).
Cells were pretreated in a final concentration of 1 mM VPA (Calbiochem).
Quantitative Western Blot Analysis
MRC5s at 60% confluency were infected at MOI = 1. To synchronize viral
entry, adsorption was done at 4C for 30 min, cells were washed once in
PBS (Mediatech), fresh medium was added, and cells placed in a 37C in
a humidified CO2 incubator. Time points were collected every 1–2 hr for 20–
24 hr as indicated. Sample collection, protein transfer, and blot preparation
were as described (Bolovan-Fritts et al., 2004), and samples were loaded
and separated on precast SDS PAGE 10% or 7.5% bisacrylamide gels
(BioRad).
For quantitative IE2 detection, the 1 antibody MAB810 (Millipore) was used
at 1:100 and 2 antibody 926-32212 (LI-COR) was used at a dilution of
1:20,000. For normalization, anti-beta tubulin antibody 26-42211 (LI-COR)
used at a dilution of 1:2,000, followed by 20 antibody 926-68073 (LI-COR) at1578 Cell 151, 1569–1580, December 21, 2012 ª2012 Elsevier Inc.a dilution of 1:20,000. Blots were scanned and quantified on a LI-COR
Odyssey according to manufacturer’s protocols.
Time-Lapse Fluorescence Microscopy Measurements
Life-extended HFFs and PML knockdown HFFs (a gift from Roger Everett)
were passed onto a 96-well glass-bottom plate (Thermo Fisher Scientific)
and grown to confluency to hold cells in the G0. Cells were synchronously in-
fected on ice for 30 min at MOI = 1 (infection with mutant was done at room
temperature). Live cells were imaged with a 203 oil objective on a spinning-
disk confocal microscope (Olympus DSU) equipped with a 37C, humidified,
5% CO2 live-cell chamber. Image collection began when YFP signal was first
detected and frames were captured every 10 min for 16–24 hr with an expo-
sure time between 200 and 800 ms. Single-cell tracking and segmentation
were performed with custom-written code in MatLab (Mathworks) as previ-
ously described (Weinberger et al., 2008). Homo-FRET imaging was per-
formed as described (Weinberger and Shenk, 2007).
Mathematical Modeling to Estimate H from Time-Lapse
Microscopy Data and Closed-Loop Analysis to Measure H
from Flow Cytometry Data
Numerical simulations and fitting of an ODEmodel (Supplemental Information)
were performed in Berkeley Madonna (www.berkeleymadonna.com).
Mathematica (Wolfram Research) was used for closed-loop analysis.
Standard lentiviral cloning was used to create minimal MIE circuits (Dull
et al., 1998). The minimal MIEP-IE2-GFP and MIEP-GFP circuits are driven
by a full-length 2.5 kb MIE promoter-enhancer (MIEP) that spans the
sequence from the MIEP modulator at the 50 edge to the junction of IE exons
1 and 2. The MIEP was PCR-cloned from AD169 into pLEIGW (a gift from Ihor
Lemishka) in place of the EF1a promoter. This full-length MIEP drives an
IE2-IRES-GFP or mCherry-IRES-GFP cassette. IE2 was cloned from pRSV-
IE86 (a gift from Jay Nelson). ARPE-19 cells were infected and FACS sorted
for GFP to create stably expressing cell lines (Figure S4). Cells were treated
with TSA for 17 hr, and GFP expression was quantified by flow cytometry.
Live cells were gated by forward-versus-side scattering on a FacsCalibur cy-
tometer (BD Biosciences) and mean fluorescence intensity recorded. At least
20,000 live cells were recorded for each experiment, and data were analyzed in
FlowJo (Treestar).
Replication Kinetics
Confluent MRC5 monolayers at 5 3 104 cells per well were infected at
indicatedMOIs with 0.45 mmprefiltered virus inoculum stocks diluted in culture
media. Inoculums were calculated based on plaque-assay titrations (Bolovan-
Fritts and Wiedeman, 2001), shown as time point 0 in each figure. Inoculum
was then removed and replaced with 1 ml of fresh medium. Infected wells
were collected in triplicate at indicated time points and stored at 80C.
To measure replication, samples were thawed and prepared as a 10-fold
serial-dilution series in culture medium analyzed by TCID50, then converted
to PFU/ml. Error ranges were calculated by standard deviation.
Minimal Synthetic Circuit Experiments
MIEPDcrs-IE2-GFP was constructed by PCR cloning MIEPDcrs from the CMV
Dcrs IE2-YFP bacmid and inserted into MIEP-IE2-GFP. ARPE-19 cells were
transduced with the MIEP-IE2-GFP and MIEPDcrs-IE2-GFP vectors and
FACS sorted for GFP. The transduced cell lines were allowed to recover for
24 hr before the percentage of GFP-expressing cells for each cell line was
quantified. Live cells were gated by forward versus side scattering on a Facs-
Calibur cytometer. On the first day after recovery, 2,500 GFP events were re-
corded. Subsequently, at least 10,000 GFP events were recorded for each
experiment and analyzed with FlowJo. For genomic PCR, genomic DNA was
purified with a NucleoSpin Tissue kit (Clontech).
Immunofluoresence and Brdu-Labeled Virus Detection
Brdu-labeled virus was grown and detected by adapting a published method
(Rosenke and Fortunato, 2004). Cells were grown on 16-well chamber slides
(Lab-Tek) and infected with either CMV IE2-YFP or Dcrs IE2-YFP virus on
ice and with 1% FCS media to synchronize infection. After 3 hr, cells were
washed, fixed, and permeabilized (Rosenke and Fortunato, 2004). PML was
detected by a polyclonal PML rabbit antibody (Santa Cruz) at a 1:500 dilution,
with secondary goat anti-rabbit Alexa 488 antibody (Invitrogen) at 1:500. After
PML detection, the cells were stained with DAPI (Invitrogen) for 15 min before
a second fixation with 3% formaldehyde. Brdu-labeled viral genomeswere de-
tected with a monoclonal rat Brdu antibody (Accurate Chemical Scientific
Corp.) at 1:250, followed by secondary donkey anti-rat antibody conjugated
with Alexa Fluor 568 (Invitrogen) at 1:500. Cells were mounted with ProLong
Gold mounting media (Invitrogen) and a #1.5 coverslip (Nunc). Coverslips
were imaged on a Zeiss Observer Z1 spinning-disk confocal microscope
with a Plan-FLUAR 1003/1.45 oil objective. Colocalization analysis was per-
formed in Slidebook 5.0 (Imaging Innovations).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, one table, and four movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2012.11.051.
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